Market Tracker

11/21 6:05pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.09
Data as of Nov 21
 -0.02 / -0.95%
Today’s Change
1.86
Today|||52-Week Range
5.30
-46.27%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close2.11
Today’s open2.10
Day’s range2.05 - 2.13
Volume216,416
Average volume (3 months)458,415
Market cap$195.8M
Dividend yield--
Data as of 4:02pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd-0.19-2.22%
AGENAgenus Inc-0.04-1.35%
PSTIPluristem Therapeuti...-0.01-0.38%
QUREUniqure NV0.000.00%
Data as of 3:59pm ET, 11/21/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President &
Chief Executive Officer
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts